Abstract
Cancer of the head and neck accounts for 3% of all the malignant diseases within the United States; however, there is an estimated societal cost of $3.1 billion spent annually for treatment. These neoplasms can be much more debilitating than other carcinomas, especially with the involvement of exposed physical attributes. Most head and neck cancer is secondary to squamous cell carcinoma. There are over 40 000 new head and neck squamous cell carcinoma (HNSCC) cancers reported each year in the United States. Multiple available imaging modalities play
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have